Group 1: Investment in Quantum Computing - The company holds a 0.97% stake in Benyuan Quantum through the Foshan Desheng Tianlin Equity Investment Partnership [2][3][4] - The investment in Benyuan Quantum was made during the A-round in 2021, reflecting an early strategic positioning in the quantum computing sector [3][4] - The company is open to future investments in the quantum computing industry and its applications [3][4] Group 2: Financial Performance - The company's revenue has decreased this year due to a strategic shift in product structure, focusing on reducing low-margin product sales [3][4] - There is a question regarding the company's ability to meet its revenue and profit targets for the year, with ongoing adjustments to operational loads to improve overall performance [4] Group 3: Employee Stock Ownership Plan - Details regarding the employee stock ownership plan's unlocking arrangements can be found in the draft published on September 2, 2025 [3][4] Group 4: Other Investments - The company has invested 1.82% in Guangzhou Yuanshang Biotechnology Co., Ltd. through the same investment partnership [4] - The company is exploring potential future investments in the biomedicine and beauty sectors [4] Group 5: Disclosure of Information - The investor relations activity did not involve any undisclosed significant information [4]
德美化工(002054) - 002054德美化工投资者关系管理信息20250919